semaglutide cardiovascular outcomes news 2025 Effects of on risk of events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials | Cardiovascular Diabetology Semaglutide Shows Secondary Cardiovascular Prevention

Gene expression analysis in soybean in response to the causal agent of Asian soybean rust ( Phakopsora pachyrhizi Sydow) in an early growth stage

As GLP-1 demand grows and traditional plans fall behind, DTE access positions employers as healthcare decision-makers, aligning benefit design with measurable outcomes in workforce health, retention, and operational efficiency

This initial phase establishes tolerance and confirms the medication is working for appetite control

Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health

Same-day consultations may be available depending on scheduling